Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_assertion type Assertion NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_head.
- NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_assertion description "[The risk of overall gastric carcinoma for SNP309 (G/G) was significantly increased when compared with T carriers (P = .039), especially carcinomas with extragastric tumors (P = .005), carcinoma with severe atrophic gastritis positive for PG assay (PG I level < 70 ng/mL and PG I/II < 3.0; P = .005), antral carcinoma (P = .020), intestinal-type carcinoma (P = .023), p53-immunopositive carcinoma (P = .007), and carcinoma with p53 mutations (P = .007).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_provenance.
- NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_assertion evidence source_evidence_literature NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_provenance.
- NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_assertion SIO_000772 16983111 NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_provenance.
- NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_assertion wasDerivedFrom befree-2016 NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_provenance.
- NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_assertion wasGeneratedBy ECO_0000203 NP569951.RA9eE_ljpZowbufWwMN7Q_U5beu4yKiehd2YZ1BvG21Qs130_provenance.